Gene: ST3GAL1
Official Full Name: ST3 beta-galactoside alpha-2,3-sialyltransferase 1provided by HGNC
Gene Summary: The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi but can be proteolytically processed to a soluble form. Correct glycosylation of the encoded protein may be critical to its sialyltransferase activity. This protein, which is a member of glycosyltransferase family 29, can use the same acceptor substrates as does sialyltransferase 4B. Two transcript variants encoding the same protein have been found for this gene. Other transcript variants may exist, but have not been fully characterized yet. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35438 | ST3GAL1 Knockout cell line (HeLa) | Human | ST3GAL1 | 1:3~1:6 | Negative | Online Inquiry |
KO35439 | ST3GAL1 Knockout cell line (HCT 116) | Human | ST3GAL1 | 1:2~1:4 | Negative | Online Inquiry |
KO35440 | ST3GAL1 Knockout cell line (HEK293) | Human | ST3GAL1 | 1:3~1:6 | Negative | Online Inquiry |
KO35441 | ST3GAL1 Knockout cell line (A549) | Human | ST3GAL1 | 1:3~1:4 | Negative | Online Inquiry |
ST3GAL1 Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the ST3GAL1 gene, which encodes for a key enzyme responsible for the biosynthesis of sialylated glycoproteins. By employing advanced CRISPR-Cas9 gene editing technology, these knockout cell lines provide researchers with a powerful tool to study the functional consequences of ST3GAL1 loss, particularly in the context of cellular signaling, immune response modulation, and cancer biology.
The key functions of ST3GAL1 include the addition of sialic acid to glycoproteins and glycolipids, a modification that influences cell-cell interactions, adhesion, and immune evasion. Understanding the role of ST3GAL1 is crucial, as its dysregulation has been linked to various diseases, including cancer and autoimmune disorders. The knockout cell lines enable scientists to dissect these complex mechanisms by allowing the observation of phenotypic changes in the absence of this specific gene.
In terms of scientific importance, ST3GAL1 Gene Knockout Cell Lines serve as valuable models in both research and clinical applications. They provide insights into the role of sialylation in disease progression and may aid in the development of targeted therapies aimed at modulating glycosylation patterns for improved therapeutic outcomes.
Compared to traditional methods such as chemical inhibition or transient knockdown approaches, our ST3GAL1 knockout cell lines offer a more stable and permanent solution for studying long-term effects of gene loss. This allows for more robust and reproducible experimental results, making them a preferred choice among researchers.
For researchers and clinicians alike, the value of ST3GAL1 Gene Knockout Cell Lines lies in their ability to facilitate significant advancements in understanding glycosylation's role in health and disease, thus paving the way for innovative treatment strategies. Our company specializes in the development of high-quality cellular models, ensuring that each product is rigorously validated to meet the needs of the research community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.